In 1929, the British Journal of Experimental Pathology published Alexander Fleming’s seminal paper, “On the Antibacterial Action of Cultures of a Penicillium, with Special Reference to their use in the Isolation of B. influenzæ.” While the world now remembers this as the “birth of antibiotics,” the 1929 paper was surprisingly modest in its claims, primarily pitching the substance as a useful tool for laboratory technicians to isolate specific bacteria.
🧫 1. The 1928 “Accident”
Fleming’s discovery is the most famous example of serendipity in science. In September 1928, upon returning from a two-week vacation, he noticed a contaminated Petri dish of Staphylococcus bacteria.
- The Observation: A mold (later identified as Penicillium notatum) had accidentally grown on the plate. Around the mold, there was a clear zone where the bacteria had dissolved—a process known as lysis.
- The “Prepared Mind”: Rather than discarding the “failed” experiment, Fleming recognized the significance of the “clear zone,” drawing on his previous 1922 discovery of lysozyme (a natural antibacterial enzyme found in tears and mucus).
🔬 2. Key Findings of the 1929 Paper
In his published analysis, Fleming detailed the properties of what he called “penicillin” (a name he coined in March 1929 to replace the clunky phrase “mould broth filtrate”).
- Selective Potency: He found that the “mould juice” was incredibly powerful, inhibiting the growth of many common pathogens (Staphylococci, Streptococci, and Diphtheria bacilli) even when diluted 800 times.
- Gram-Negative Immunity: Crucially, he noted that it had no effect on Gram-negative bacteria like B. influenzæ (now Haemophilus influenzae) or typhoid bacteria.
- Non-Toxicity: Fleming performed early toxicity tests on rabbits and mice, discovering that, unlike the harsh antiseptics of the era, penicillin did not interfere with leukocytes (white blood cells), the body’s primary defense system.
- The Original Proposed Use: Ironically, Fleming did not initially see it as an internal medicine. He suggested it be used to help bacteriologists grow pure cultures of B. influenzæ by killing off the “weeds” (the sensitive bacteria) in a sample.
⏳ 3. The “Decade of Silence” (1929–1939)
Despite the paper’s clear evidence, penicillin did not become a drug overnight.
- The Stability Problem: Penicillin was notoriously unstable and difficult to purify. Fleming’s “mold juice” would lose its potency within days.
- Lack of Chemistry Expertise: Fleming was a bacteriologist, not a chemist. He lacked the specialized equipment and knowledge to isolate the active molecule in a stable, concentrated form.
- The 1930s Lull: For ten years, the paper sat in the archives of medical libraries, used only by a few lab technicians for the selective culture method Fleming had described.
🏥 4. The Path to the “Wonder Drug”
The transition from a “lab tool” to a “life-saver” required a new team and a global crisis:
- The Oxford Team (1939): Howard Florey and Ernst Chain rediscovered Fleming’s 1929 paper while looking for natural antibacterial substances.
- Purification: Using advanced chemical techniques (including freeze-drying), they finally produced a stable, concentrated powder.
- WWII Demand: The desperate need for a way to treat infected wounds on the battlefield accelerated production from “bedpans in a lab” to massive fermentation vats in the United States.
- The Nobel Prize (1945): Fleming, Florey, and Chain shared the Nobel Prize in Physiology or Medicine for turning a “funny” observation in a Petri dish into the world’s first antibiotic.
2026 Perspective: We are now facing the “post-antibiotic era” that Fleming himself warned about in his 1945 Nobel speech. By early 2026, researchers are using AI-driven drug discovery to find “next-gen” penicillins that can bypass the resistance mechanisms bacteria have developed over the last century.
About The Author
